Recruitment

Recruitment Status
Active, not recruiting
Estimated Enrollment
20

Summary

Conditions
  • Acute Chest Syndrome
  • Sickle Cell Disease
Type
Interventional
Phase
Phase 2
Design
Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment

Participation Requirements

Age
Between 2 years and 40 years
Gender
Both males and females

Description

Not Provided

Not Provided

Tracking Information

NCT #
NCT03805581
Collaborators
Johns Hopkins University
Investigators
Principal Investigator: Mitchell S Cairo, MD New York Medical College